Sustained response to single agent therapy with continuous lenalidomide in a pre-treated high-risk multiple myeloma patient | springermedizin.at

Springer Medizin Österreich

nach oben

memo - Magazine of European Medical Oncology

Erschienen in:

01.04.2012 | Case report

Sustained response to single agent therapy with continuous lenalidomide in a pre-treated high-risk multiple myeloma patient

verfasst von: E. Willenbacher, W. Willenbacher, E. Gunsilius, MD

Erschienen in: memo - Magazine of European Medical Oncology | Ausgabe 1/2012

Einloggen, um Zugang zu erhalten

Anzeige

Vorheriger Artikel Continuous treatment with lenalidomide in multiple myeloma: a case report

Nächster Artikel Prevention and treatment of febrile neutropenia

Titel: Sustained response to single agent therapy with continuous lenalidomide in a pre-treated high-risk multiple myeloma patient
verfasst von: E. Willenbacher
W. Willenbacher
E. Gunsilius, MD
Publikationsdatum: 01.04.2012
Verlag: Springer Vienna
Erschienen in: memo - Magazine of European Medical Oncology / Ausgabe 1/2012
Print ISSN: 1865-5041
Elektronische ISSN: 1865-5076
DOI: https://doi.org/10.1007/s12254-012-0345-0

Weitere Artikel der Ausgabe 1/2012

Therapy of AL amyloidosis – work-up and treatment at our centre

Short review

Medical aspects in oncological rehabilitation

Short review

Parenteral nutrition for symptom control in a patient with pancreatic cancer and generalized oedema – a case report

Case report

Gastrointestinal manifestation of amyloidosis

Short review

Prevention and treatment of febrile neutropenia

Review

Renal aspects of amyloidosis

Short review